.jpg?format=webp&width=780)
Using data from 2017, the authors have previously examined the coverage of obesity‐related services in state employee health plans since 2009 and found improvements in coverage for obesity‐related treatments. This study repeated the collection of similar data for 2021 and explored whether coverage had continued to increase or decline. Despite promising new therapies, states in 2021 were less likely to provide coverage for antiobesity medications. Additionally, limited use data suggested that few eligible individuals may be receiving these services. In conclusion, state employee health plans are currently inadequate given the prevalence, severity, and costs of obesity.
Like
Save
Share